Silverback Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.6M | 345k | 10.55 |
| 2024-09-30 | $327k | 23k | 14.50 |
| 2024-06-30 | $224k | 26k | 8.51 |
| 2024-03-31 | $311k | 30k | 10.22 |
| 2023-12-31 | $96k | 17k | 5.48 |
| 2022-12-31 | $97k | 11k | 8.53 |